Home › Funds › Paradigm Biocapital Advisors LP › RVMD
Paradigm Biocapital Advisors LP position in RVMD
REVOLUTION MEDICINES INC · Health Care
Paradigm Biocapital Advisors LP reported holding 6,219,323 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$1.28B, representing 25.38% of its reported portfolio and ranking #1 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed RVMD holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Paradigm Biocapital Advisors LP's RVMD position evolved
Paradigm Biocapital Advisors LP first disclosed a stake in RVMD in Q1 2024 at 2,914,975 shares (US$93.9M). The position peaked in Q3 2026 at 6,219,323 shares, worth US$1.28B. Across 11 filings, Paradigm Biocapital Advisors LP increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 6,219,323 shares valued at US$1.28B — a reduction of -142,000 shares quarter over quarter.. Notable position changes include a 80% increase in Q2 2024 (shares rose 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 2.91M | $93.95M | New |
| Q2 2024 | 5.26M | $204.11M | Add |
| Q3 2024 | 5.31M | $240.99M | Add |
| Q4 2024 | 6.55M | $286.63M | Add |
| Q1 2025 | 6.18M | $218.46M | Reduce |
| Q2 2025 | 6.09M | $224.17M | Reduce |
| Q3 2025 | 6.22M | $290.63M | Add |
| Q4 2025 | 6.64M | $529.23M | Add |
| Q1 2026 | 6.66M | $647.27M | Hold |
| Q2 2026 | 6.36M | $1.19B | Reduce |
| Q3 2026 | 6.22M | $1.28B | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RVMD and 13F data
RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 54 other funds we track also report a position in RVMD — the largest reported positions include FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.75B), Farallon Capital Management (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RVMD
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.42M sh · $2.75B · Q3 2026
- Farallon Capital Management 13.55M sh · $2.54B · Q2 2026
- BAKER BROS. ADVISORS LP 11.44M sh · $2.14B · Q2 2026
- Darwin Global Management, Ltd. 10.63M sh · $2.05B · Q2 2026
- Nextech Invest Ltd. 7.60M sh · $1.42B · Q2 2026
- Janus Henderson Group 9.77M sh · $949.54M · Q1 2026
- BVF INC/IL 2.97M sh · $555.32M · Q2 2026
- Alphabet Inc. 2.67M sh · $548.85M · Q3 2026
- Casdin Capital 2.58M sh · $482.68M · Q2 2026
- Assenagon Asset Management S.A. 2.18M sh · $447.71M · Q3 2026
- Avoro Capital Advisors LLC 2.15M sh · $440.28M · Q3 2026
- Nearwater Capital Markets, Ltd 1.79M sh · $367.00M · Q3 2026
More on Paradigm Biocapital Advisors LP
FAQ
How long has Paradigm Biocapital Advisors LP held RVMD?
Paradigm Biocapital Advisors LP has disclosed RVMD holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Paradigm Biocapital Advisors LP's current position in RVMD?
As of Q3 2026, Paradigm Biocapital Advisors LP holds 6.22M shares of RVMD (REVOLUTION MEDICINES INC), valued at $1.28B, representing 25.38% of its reported portfolio and ranking #1.
Has Paradigm Biocapital Advisors LP been buying or selling RVMD?
In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP reduced its position in RVMD. The position peaked in Q3 2026 at 6.22M shares.
Which other funds hold RVMD?
Other major institutional holders of RVMD include FARALLON CAPITAL MANAGEMENT, L.L.C., Farallon Capital Management, BAKER BROS. ADVISORS LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.